Clinical Roundup T-cell receptor therapy shows early anti-tumor activity in phase I study January 13, 2023Vol.49 No.02
Drugs & Targets Foundation Medicine & Natera provide early access to personalized circulating tumor DNA monitoring assay January 13, 2023Vol.49 No.02
Drugs & Targets Kronos Bio & Genentech to collaborate on therapies against transcriptional targets January 13, 2023Vol.49 No.02
Capitol Hill NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority January 06, 2023Vol.49 No.01By Matthew Bin Han Ong
In Brief Medicare and insurance changes remove barriers for stool-based CRC screening January 06, 2023Vol.49 No.01
In Brief Sheri Robb named Walther Professor in Supportive Oncology at Indiana University January 06, 2023Vol.49 No.01
In Brief Zachary J. Roberts named executive vice president of R&D at Allogene January 06, 2023Vol.49 No.01
Funding Opportunities FDA issues RFA to improve health equity in oncology therapeutic development January 06, 2023Vol.49 No.01
